comparemela.com

Latest Breaking News On - Addex therapeutics daily - Page 1 : comparemela.com

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Update

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 5,500 shares, a drop of 62.6% from the April 30th total of 14,700 shares. Based on an average trading volume of 19,800 shares, the days-to-cover ratio […]

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Up 41 7% in March

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 11,900 shares, a growth of 41.7% from the February 29th total of 8,400 shares. Based on an average daily volume of 9,600 shares, the short-interest ratio […]

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Update

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Down 14 3% in December

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 3,600 shares, a drop of 14.3% from the November 30th total of 4,200 shares. Based on an average trading volume of 8,100 shares, […]

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Down 95 4% in October

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 5,300 shares, a decrease of 95.4% from the September 30th total of 115,900 shares. Based on an average daily trading volume, of 4,000 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.